Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Establishment and Characterization of New Murine Breast Cancer Cell Lines.
Bernhardt G, Beckenlehner K, Spruss T, Schlemmer R, Reile H, Schönenberger H. Bernhardt G, et al. Among authors: schlemmer r. Arch Pharm (Weinheim). 2002 May;335(2):55-68. doi: 10.1002/1521-4184(200205)335:2<55::AID-ARDP55>3.0.CO;2-W. Arch Pharm (Weinheim). 2002. PMID: 12007108
Establishment and characterization of new murine breast cancer cell lines.
Bernhardt G, Beckenlehner K, Spruss T, Schlemmer R, Reile H, Schönenberger H. Bernhardt G, et al. Among authors: schlemmer r. Arch Pharm (Weinheim). 2002 Mar;335(2-3):55-68. doi: 10.1002/1521-4184(200203)335:2/3<55::AID-ARDP55>3.0.CO;2-Y. Arch Pharm (Weinheim). 2002. PMID: 12043456
[1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) complexes, compounds for the endocrine therapy of breast cancer - mode of action I: antitumor activity due to the reduction of the endogenous estrogen level.
Schertl S, Hartmann RW, Batzl-Hartmann C, Bernhardt G, Spruss T, Beckenlehner K, Koch M, Krauser R, Schlemmer R, Gust R, Schönenberger H. Schertl S, et al. Among authors: schlemmer r. Arch Pharm (Weinheim). 2004 Jun;337(6):335-48. doi: 10.1002/ardp.200300855. Arch Pharm (Weinheim). 2004. PMID: 15188223
[1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) complexes, compounds for the endocrine therapy of breast cancer - mode of action II: contribution of drug inactivation, cellular drug uptake and sterical factors in the drug-target interaction to the antitumor activity.
Schertl S, Hartmann RW, Batzl-Hartmann C, Bernhardt G, Spruss T, Beckenlehner K, Koch M, Krauser R, Schlemmer R, Gust R, Schönenberger H. Schertl S, et al. Among authors: schlemmer r. Arch Pharm (Weinheim). 2004 Jun;337(6):349-59. doi: 10.1002/ardp.200300856. Arch Pharm (Weinheim). 2004. PMID: 15188224
Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part 1: The MXT-M-3.2 breast cancer stimulates the growth of an identical second graft; [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplat inum (II) inhibits this process.
Schlemmer R, Spruss T, Bernhardt G, Schönenberger H. Schlemmer R, et al. Arch Pharm (Weinheim). 2000 Mar;333(2-3):69-71. doi: 10.1002/(sici)1521-4184(200002)333:2/3<69::aid-ardp69>3.0.co;2-d. Arch Pharm (Weinheim). 2000. PMID: 10783521
Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part II. Studies on the influence of [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) on the specific immune defense in MXT-M-3,2 breast cancer bearing mice.
Schlemmer R, Spruss T, Bernhardt G, Schönenberger H. Schlemmer R, et al. Arch Pharm (Weinheim). 2000 Dec;333(12):397-403. doi: 10.1002/1521-4184(200012)333:12<397::aid-ardp397>3.0.co;2-f. Arch Pharm (Weinheim). 2000. PMID: 11199469
Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloro-platinum(II) act as an immune response modifier? Part III: Progressively growing MXT-M-3,2 breast cancer stimulates the proliferation of phagocytes in B6D2F1 mice.
Schlemmer R, Spruss T, Bernhardt G, Schönenberger H. Schlemmer R, et al. Arch Pharm (Weinheim). 2000 Dec;333(12):404-14. doi: 10.1002/1521-4184(200012)333:12<404::aid-ardp404>3.0.co;2-m. Arch Pharm (Weinheim). 2000. PMID: 11199470
1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethanes--new biological response modifiers for the therapy of breast cancer. Synthesis and evaluation of estrogenic/antiestrogenic properties.
Schertl S, Hartmann RW, Batzl-Hartmann C, Schlemmer R, Spruss T, Bernhardt G, Gust R, Schönenberger H. Schertl S, et al. Among authors: schlemmer r. Arch Pharm (Weinheim). 2001 Apr;334(4):125-37. doi: 10.1002/1521-4184(200104)334:4<125::aid-ardp125>3.0.co;2-d. Arch Pharm (Weinheim). 2001. PMID: 11382148
41 results